AKT1 and nasopharyngeal carcinoma: Thus, a combinatorial approach of targeting TRAF4 or its downstream molecule, such as Akt with IR, would elevate the therapeutic effect of irradiation on nasopharyngeal carcinoma, which provides novel insights into rational cancer treatment.